Directory
>
Katy Barglow
Katy Barglow
Senior Vice President | 4D Molecular Therapeutics
Walnut Creek, California, United States
Katy Barglow
Summary
Katy Barglow is a highly accomplished CMC leader in the gene therapy sector, currently serving as the Senior Vice President of Technical Operations at 4D Molecular Therapeutics. With a robust background in biochemistry and molecular biology, she has spearheaded critical advancements in process development and clinical manufacturing of AAV gene therapies. Katy's expertise extends to analytical development, quality control, and regulatory strategy, showcasing her ability to navigate complex CMC requirements for pre-clinical and clinical products. She has a track record of driving innovation and efficiency in laboratory settings, evidenced by her contributions to assay development and process optimization. Her publication record reflects her commitment to advancing scientific understanding in proteomics and enzymology. Katy's leadership experience is complemented by her hands-on approach to project management and team development, making her a pivotal figure in her organization. She holds a PhD in Biochemistry and has been instrumental in fostering collaborations that bridge academia and industry.
Katy Barglow
Work Experience
Senior Vice President at
4D Molecular Therapeutics
January 2022 - Present
Vice President Technical Operations at
4D Molecular Therapeutics
January 2021 - March 2022
Vice President, Process and Analytical Developmen at
4D Molecular Therapeutics
January 2019 - January 2021
Director, Process Sciences and Analytical Development at
4D Molecular Therapeutics
June 2017 - January 2019
Analytical Group Leader at
Grifols
August 2014 - June 2017
Research Scientist II at
Baxter International Inc.
August 2012 - August 2014
Temporary Research Scientist at
Dophen Biomedical
June 2012 - August 2012
Staff Scientist I at
Catalyst Biosciences
August 2011 - May 2012
Postdoctoral Fellow at
The University California Berkeley
July 2008 - August 2011
Graduate Student at
The Scripps Research Institute
September 2002 - June 2008
Katy Barglow
Education
University of California, Berkeley, Postdoctoral Fellow
January 2008 - January 2011
The Scripps Research Institute, Doctor Of Philosophy (Phd)
January 2002 - January 2008
Stanford University, B.S
January 1998 - January 2002
Frequently Asked Questions about Katy Barglow
What is Katy Barglow email address?
Katy Barglow's primary email address is ************@grifols.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Katy Barglow work for?
Katy Barglow is a Senior Vice President at 4D Molecular Therapeutics, a company specializing in Commercial physical research.
Where Katy Barglow graduated from?
Katy Barglow holds a degree in from University of California, Berkeley.
How can I directly contact Katy Barglow?
To contact Katy Barglow directly, you can use the email address ************@grifols.com. Complete contact information is available upon registration with Muraena.
Who is Katy Barglow?
Katy Barglow is a highly accomplished CMC leader in the gene therapy sector, currently serving as the Senior Vice President of Technical Operations at 4D Molecular Therapeutics. With a robust background in biochemistry and molecular biology, she has spearheaded critical advancements in process development and clinical manufacturing of AAV gene therapies. Katy's expertise extends to analytical development, quality control, and regulatory strategy, showcasing her ability to navigate complex CMC requirements for pre-clinical and clinical products. She has a track record of driving innovation and efficiency in laboratory settings, evidenced by her contributions to assay development and process optimization. Her publication record reflects her commitment to advancing scientific understanding in proteomics and enzymology. Katy's leadership experience is complemented by her hands-on approach to project management and team development, making her a pivotal figure in her organization. She holds a PhD in Biochemistry and has been instrumental in fostering collaborations that bridge academia and industry.
Katy`s contact details
************@grifols.com
********@berkeley.edu
********@4dmoleculartherapeutics.com
Colleagues
Chief Legal Officer
Chief Of Staff
Senior Vice President - Clinical Development, Therapeutic Area Head - Pulmonology
Chief Research & Translational Development Officer
Chief Medical Officer
SVP, Clinical Development Operations
Board Member
Vice President, Early-Stage Product Development
Executive Business Partner, CEO Office
Co-Founder & Board Director: Life Sciences Entrepreneurship Center